Duty calculator › Tariff programs
Section 232: pharmaceuticals
In force · Section 232 of the Trade Expansion Act of 1962 · HTS chapter 99, subchapter III, U.S. note 40
Patented pharmaceutical articles on the ten-digit lines listed in U.S. note 40(c) (a drug under a valid U.S. patent that is listed in the FDA Orange Book or Purple Book, and its active ingredients and key starting materials) are dutiable at 100 percent in total, in place of the column 1 rate, in full effect since September 29, 2026. The total is 15 percent for products of Japan, the European Union, South Korea, Switzerland and Liechtenstein, and nothing is added for products of the United Kingdom, qualifying specialty drugs, companies with both an onshoring plan and a pricing agreement (an onshoring plan alone pays an additional 20 percent), dosage products with a U.S. active ingredient, goods solely for clinical trials or research, generic drugs and other listed articles that are not patented pharmaceutical articles. The headings are mutually exclusive, so the tool reports the lowest rate that fits; give the 10-digit code, because the list is made of 10-digit statistical lines.
Common products it adds duty to
None of the 47 products on the duty by product pages picks up a layer from it for the 20 largest origins with default assumptions.
Check any HTS line and origin in the free duty calculator, or ask Claude with the free Sanctions & Tariff Lookup connector (tools duty_stack and compare_origins). Several lines at once: the shipment duty estimate adds up to 200 lines (HTS code, origin, value) into one PDF report with every layer per line.
Questions
What is Section 232: pharmaceuticals?
Patented pharmaceutical articles on the ten-digit lines listed in U.S. note 40(c) (a drug under a valid U.S. patent that is listed in the FDA Orange Book or Purple Book, and its active ingredients and key starting materials) are dutiable at 100 percent in total, in place of the column 1 rate, in full effect since September 29, 2026. The total is 15 percent for products of Japan, the European Union, South Korea, Switzerland and Liechtenstein, and nothing is added for products of the United Kingdom, qualifying specialty drugs, companies with both an onshoring plan and a pricing agreement (an onshoring plan alone pays an additional 20 percent), dosage products with a U.S. active ingredient, goods solely for clinical trials or research, generic drugs and other listed articles that are not patented pharmaceutical articles. The headings are mutually exclusive, so the tool reports the lowest rate that fits; give the 10-digit code, because the list is made of 10-digit statistical lines.
Is Section 232: pharmaceuticals in force?
Yes, under rules version 46ce9712bc246f6d built from 2026 HTS Revision 23. The duty calculator adds it whenever a line and origin fall under it.
Which products does Section 232: pharmaceuticals apply to?
None of the 47 common products on this site's duty pages picks up a layer from it for the 20 largest origins with default assumptions. Check a specific HTS line in the free duty calculator.
Is this a customs ruling?
No. It is an estimate for a person to review. Classification, origin and the duty owed are decided under customs law; confirm them with U.S. Customs and Border Protection or a licensed customs broker. Antidumping and countervailing duties, quotas and fees are not included.
Sources
- Proclamation 11020 of April 2, 2026, Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients Into the United States, 91 FR 18183 (April 9, 2026)
- Bureau of Industry and Security, Procedures To Apply for Company-Specific Onshoring Agreements To Obtain Tariff Adjustments for Pharmaceuticals and Pharmaceutical Ingredients Under Proclamation 11020, 91 FR 26989 (May 13, 2026)
- Bureau of Industry and Security, Notice of Reduction of Tariffs on Patented Pharmaceuticals and Pharmaceutical Ingredients for Products of the United Kingdom Implemented by Presidential Proclamation 11020, 91 FR 49406 (August 4, 2026)
- Bureau of Industry and Security, Guidance and Procedures for Implementing Tariff Adjustments for Specialty Pharmaceuticals and Associated Pharmaceutical Ingredients and Technical Corrections to the Harmonized Tariff Schedule of the United States for Duties Imposed Under Proclamation 11020, 91 FR 60360 (September 23, 2026)
- U.S. Customs and Border Protection, CSMS # 70054007, Updated Guidance: Section 232 Duties on Imports of Pharmaceutical Articles and Ingredients (September 28, 2026)
- HTS chapter 99, subchapter III, U.S. note 40 and headings 9903.04.60 to 9903.04.70
Other tariff programs
Section 232: passenger vehicles, light trucks and parts · Section 232: medium- and heavy-duty vehicles and parts · Section 232: timber, lumber and wood products · Section 232: semiconductors · Section 232: unmanned aircraft systems · Section 232: steel, aluminum and copper · Section 301: China (2018 action) · Section 301: China (2024 four-year review increases) · Section 301: forced-labor action (60 economies) · Section 301: Brazil · Section 338: Canada · Column 2 duty increases for Russia · IEEPA duties (fentanyl-related and reciprocal tariffs) · Section 122 temporary import surcharge
Found a wrong result? Tell us through the support form with the HTS code and the country.